Mammalian target of rapamycin (mTOR)‐related non‐infectious pneumonitis: a potential biomarker of clinical benefit?

E-ISSN： 1464-410x|113|3|350-351

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.113, Iss.3, 2014-03, pp. : 350-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mammalian target of rapamycin (mTOR) inhibitor‐associated non‐infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 376-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1199-1207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phosphorylation of the ribosomal protein S6, a marker of mTOR (mammalian target of rapamycin) pathway activation, is strongly increased in hypertrophic scars and keloids

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 5, 2015-05 ,pp. : 1415-1417

John Wiley & Sons Inc

Access to resources Recommend Favorite

Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 44, Iss. 1, 2018-02 ,pp. : 6-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Treatment with Mammalian Target of Rapamycin Inhibitor Does Not Benefit Patients with Autosomal Dominant Polycystic Kidney Disease: A Meta-Analysis

Nephron Clin Pract, Vol. 124, Iss. 1-2, 2013-09 ,pp. : 10-16

Karger

Access to resources Recommend Favorite